Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Matrixx reaffirms safety of Zicam intranasal gel

Feb. 12, 2004

Zambon and BioXell to develop new CXCR3 antagonists

Feb. 10, 2004

Early access program for pirfenidone in IPF

Feb. 10, 2004

Novel pyridazine-based PDE4 inhibitors covered by Merck KGaA patent

Feb. 9, 2004

Novel muscarinic M3 antagonists identified at Almirall Prodesfarma

Feb. 6, 2004

Novel histamine H3 antagonists in early development at Schering-Plough

Feb. 6, 2004

Altana sustains growth throughout 2003

Feb. 5, 2004

FDA approval for Spiriva HandiHaler

Feb. 4, 2004

Altana and Signal scientists identify novel PKC-theta inhibitors

Feb. 2, 2004

New pyridazine-based PDE4 inhibitors and their use reported by Merck KGaA

Feb. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...